Gobert Alain P, Bambou Jean-Christophe, Werts Catherine, Balloy Viviane, Chignard Michel, Moran Anthony P, Ferrero Richard L
Unité de Pathogénie Bactérienne des Muqueuses, INSERM E336, Institut Pasteur, Paris Cedex15, France.
J Biol Chem. 2004 Jan 2;279(1):245-50. doi: 10.1074/jbc.M307858200. Epub 2003 Oct 22.
Helicobacter pylori has been reported to induce interleukin-6 (IL-6) production in monocytes/macrophages and in chronically inflamed gastric tissues. The mechanism by which H. pylori induces IL-6 production in macrophages, however, has not been investigated. To identify the H. pylori factor responsible for this activity, we fractionated soluble proteins from H. pylori strain 26695 by ion exchange and size exclusion chromatography and screened the fractions for IL-6-inducing activity on RAW 264.7 macrophages. A single protein was purified and identified by mass spectrometry as H. pylori heat shock protein 60 (HSP60). Consistent with the observed IL-6-inducing activity of H. pylori HSP60, soluble protein extracts of H. pylori 26695 and SS1 strains that were depleted of this protein by affinity chromatography had dramatically reduced IL-6-inducing activities. The immunopurified HSP60 stimulated IL-6 production in macrophages. When stimulated with H. pylori HSP60 or intact bacteria, peritoneal macrophages from mice deficient in Toll-like receptor (TLR)-2, TLR-4, TLR-2/TLR-4, and myeloid differentiation factor 88 produced the same amount of IL-6 than macrophages from wild-type mice, demonstrating the independence of H. pylori HSP60 responses from these signaling molecules. H. pylori HSP60-induced IL-6 mRNA expression, and NF-kappaB activation in RAW 264.7 cells was abrogated in the presence of MG-132, a proteasome inhibitor. In contrast, inhibitors of protein kinase A or C, mitogen-activated protein kinase kinase, and phosphoinositide 3-kinase had no effect on IL-6 mRNA levels. This study demonstrates the induction of innate immune responses by H. pylori HSP60, thereby implicating this highly conserved protein in the pathophysiology of chronic gastritis.
据报道,幽门螺杆菌可诱导单核细胞/巨噬细胞以及慢性炎症胃组织中白细胞介素-6(IL-6)的产生。然而,幽门螺杆菌诱导巨噬细胞产生IL-6的机制尚未得到研究。为了确定负责此活性的幽门螺杆菌因子,我们通过离子交换和尺寸排阻色谱法对幽门螺杆菌26695菌株的可溶性蛋白进行了分级分离,并筛选了各组分对RAW 264.7巨噬细胞的IL-6诱导活性。一种单一蛋白质被纯化,并通过质谱鉴定为幽门螺杆菌热休克蛋白60(HSP60)。与观察到的幽门螺杆菌HSP60的IL-6诱导活性一致,通过亲和色谱法去除该蛋白的幽门螺杆菌26695和SS1菌株的可溶性蛋白提取物的IL-6诱导活性显著降低。免疫纯化的HSP60刺激巨噬细胞产生IL-6。当用幽门螺杆菌HSP60或完整细菌刺激时,来自Toll样受体(TLR)-2、TLR-4、TLR-2/TLR-4和髓样分化因子88缺陷小鼠的腹膜巨噬细胞产生的IL-6量与野生型小鼠的巨噬细胞相同,表明幽门螺杆菌HSP60反应独立于这些信号分子。在蛋白酶体抑制剂MG-132存在的情况下,幽门螺杆菌HSP60诱导的RAW 264.7细胞中IL-6 mRNA表达和NF-κB激活被消除。相比之下,蛋白激酶A或C、丝裂原活化蛋白激酶激酶和磷酸肌醇3激酶的抑制剂对IL-6 mRNA水平没有影响。这项研究证明了幽门螺杆菌HSP60可诱导先天性免疫反应,从而表明这种高度保守的蛋白质参与了慢性胃炎的病理生理过程。